Skip to Main Content

Insights from First Securities Fraud Class-Action Suit Against a Drug Manufacturer Developing a COVID-19 Vaccine

Baker Recommends
April 21, 2020
2:00 PM Eastern


April 21, 2020
2:00 PM Eastern

Join Baker Donelson shareholder Matt Chester for the Celesq AttorneysEd Center Webcast "Insights from First Securities Fraud Class Action Against a Company Developing a COVID-19 Vaccine" on April 21 at 2:00 p.m.

This program will focus on heightened risk factors for publicly traded companies when providing information to investors and provide insights about such risk factors using the recent securities fraud class action filed against Inovio Pharmaceuticals Inc. and its CEO as an example. It will review the theories of securities fraud commonly relied upon, such as the fraud-on-the market theory, along with measures to avoid or limit these risks.

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept